Posted by
pmrcorporate
1 day 14 hours ago
(http://www.pmrcorporate.com)
Category: Research & Development |
Discuss Add this link to... Bury
Will Warn About Risk Of Serious Neuropsychiatric Symptoms Including Agitation, Depression, Suicidal Thoughts, And Attempted Suicide
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Accutane Recall Due To Safety Issues Or Declining Sales Or Lawsuit Losses Or Some Combination Of These Factors?
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Finalising a review of the safety and efficacy of dextropropoxyphene-containing medicines, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) concluded that their r
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
AstraZeneca and Bristol-Myers Squibb Company today announced that their marketing authorisation application for ONGLYZA (saxagliptin) received a positive opinion from the Committee for Medicinal Prod
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
H. Lundbeck A/S (LUN.CO; LUN DC) has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for Serdolect® (sertindole) for the treatment of schizophrenia.
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
FDA And U.S. Marshals Seize Drug Products From Caraco’s Three Michigan Facilities Due To Continuing Lack Of Quality Controls
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
When people discuss the ever-rising costs of health care, one of the most common complaints is the sometimes exorbitant price of prescription medicines.
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The European Medicines Agency is inviting comments on its draft transparency policy until 25 September 2009. Since its inauguration in 1995, the Agency has worked continuously to improve the transpar
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Pfizer has announced results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic islet cell tumors, also known as pancreatic neuroendocrine tumors, which
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
